These findings indicate that mutation of the vaccine’s Env ISD increases an induction of cytotoxic T cells (CTLs), and in conjunction with α-PD1 is capable of eradicating aggressive and established tumours in mice. The gene discussed is ERVW-1; the disease is neoplasm.